#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux


Authors: L. Nosáková;  Ďuriček M.;  P. Bánovčin Jr.;  Gburová D.;  Lipták P.;  Hyrdel R.
Authors‘ workplace: Interná klinika gastroenterologická JLF UK a UN Martin
Published in: Gastroent Hepatol 2019; 73(1): 56-61
Category: Clinical and Experimental Gastroenterology: Original Article
doi: https://doi.org/10.14735/amgh201956

Overview

Laryngopharyngeal reflux (LPR) is according to the current conception responsible for extraesophageal symptoms of gastroesophageal reflux disease. It is manifested by non-specific problems like cough, excess throat mucus, globus and others. The diagnosing is complicated as currently there is no diagnostic test which could definitely establish the association of LPR and emerged troubles. The therapeutic trial with proton pump inhibitors (PPIs) is a common clinical practice. In this study we have evaluated its efficiency in patients classified on the basis of symptoms. At the first visit patients filled in a reflux symptom index (RSI) questionnaire. In case of RSI positivity (RSI > 13) the PPI therapy twice daily was used during the next 3 months. Then we invited the patients for a check-up during which they filled in the RSI questionnaire again. We have found significant moderation of symptoms after the 3 months’ PPI treatment and the normalization of RSI (RSI ≤ 13) was achieved by 50% of patients. When assessing the treatment efficiency on the individual questions in the questionnaire we have ascertained the significant influence on the cough reduction after eating and in a lying position, troublesome cough, breathing difficulties and choking episodes. Therapeutic trial seems to be an effective way of initial management of patients with anticipated LPR which can be used after the cause of the problems is ruled out by other specialists.

Key words:

laryngopharyngeal reflux – reflux symptom index – proton pump inhibitors – gastroesophageal reflux disease.

This publication was created thanks to sup­port under the Research and Development Operational Program for the project: Measurement of Respiratory Tract Destruction Kinetics, ITMS project code: 26220220019, co-funded by the European Regional Development Fund.

Submitted: 16. 7. 2018

Accepted: 24. 1. 2019


Sources

1. Martinucci I, de Bortoli N, Savarino E et al. Optimal treatment of laryngopharyngeal reflux dis­ease. Ther Adv Chronic Dis 2013; 4(6): 287–301. doi: 10.1177/2040622313503485.

2. Campagnolo AM, Priston J, Thoen RH et al. Laryngopharyngeal reflux: dia­gnosis, treatment, and latest research. Int Arch Otorhinolaryngol 2014; 18(2): 184–191. doi: 10.1055/s-0033-1352504.

3. Varechova S, Mikler J, Murgas D et al. Cough reflex sensitivity in children with suspected and confirmed gastroesophageal reflux dis­ease. J Physiol Pharmacol 2007; 58 Suppl 5(Pt 2): 717–727.

4. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symp­tom index (RSI). J Voice 2002; 16(2): 274–277.

5. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux find­­ing score (RFS). Laryngoscope 2001; 111(8): 1313–1317. doi: 10.1097/00005537-200108000-00001.

6. Vailati C, Mazzoleni G, Bondi S et al. Oropharyngeal pH monitor­­ing for laryngopharyngeal reflux: is it a reliable test before ther­apy? J Voice 2013; 27(1): 84–89. doi: 10.1016/j.jvoice.2012.08.006.

7. Zerbib F, des Varan­nes SB, Roman S et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitor­­ing in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22(10): 1011–1021. doi: 10.1111/j.1365-2036.2005.02677.x.

8. Zelenik K, Matousek P, Tedla M et al. Extraesophageal reflux: what is the best parameter for ph-monitor­­ing data analysis from the perspective of patient response to proton pump inhibitors? Gastroenterol Res Pract 2013; 2013: 736486. doi: 10.1155/2013/736486.

9. Johnston N, Dettmar PW, Strugala V et al. Laryngopharyngeal reflux and GERD. Ann N Y Acad Sci 2013; 1300: 71–79. doi: 10.1111/nyas.12237.

10. Duricek M, Banovcin P, Halickova T et al. Acidic pharyngeal reflux does not cor­relate with symp­toms and laryngeal injury attributed to laryngopharyngeal reflux. Dig Dis Sci 2018. doi: 10.1007/s10620-018-5372-1.

11. Social Science Statistics. [online]. Dostupné z:http://www.socscistatistics.com/tests/mannwhitney/.

12. Wei C. A meta-analysis for the role of proton pump inhibitor ther­apy in patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2016; 273(11): 3795–3801. doi: 10.1007/s00405-016-4142-y.

13. Leite LP, Johnston BT, Just RJ et al. Persistent acid secretion dur­­ing omeprazole ther­apy: a study of gastric acid profiles in patients demonstrat­­ing failure of omeprazole ther­apy. Am J Gastroenterol 1996; 91(8): 1527–1531.

14. Park W, Hicks DM, Khandwala F et al. Laryngopharyngeal reflux: prospective cohort study evaluat­­ing optimal dose of proton-pump inhibitor ther­apy and prether­apy predictors of response. Laryngoscope 2005; 115(7): 1230–1238. doi: 10.1097/01.MLG.0000163746.81766.45.

15. Waxman J, Yalamanchali S, Val­le ES et al. Ef­fects of proton pump inhibitor ther­apy for laryngopharyngeal reflux on posttreatment symp­toms and hypopharyngeal pH. Otolaryngol Head Neck Surg 2014; 150(6): 1010–1017. doi: 10.1177/0194599814525577.

16. Lechien JR, Finck C, Khalife M et al. Change of signs, symp­toms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux dis­ease. Clin Otolaryngol 2018; 43(5): 1273–1282. doi: 10.1111/coa.13140.

17. Lam PK, Ng ML, Cheung TK et al. Rabeprazole is ef­fective in treat­­ing laryngopharyngeal reflux in a randomized placebo-control­led trial. Clin Gastroenterol Hepatol 2010; 8(9): 770–776. doi: 10.1016/j.cgh.2010.03.009.

18. Duricek M, Nosakova L, Zatko T et al. Cough reflex sensitivity does not cor­relate with the esophageal sensitivity to acid in patients with gastroesophageal reflux dis­ease. Respir Physiol Neurobio­l 2018; 257: 25–29. doi: 10.1016/j.resp.2018.03.011.

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#